Bullish Prospects For Alpha Tau Medical Ltd. (NASDAQ: DRTS) Shares In 2022

Alpha Tau Medical Ltd. (NASDAQ:DRTS) price on Wednesday, March 23, rose 14.15% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $11.78.

A look at the stock’s price movement, the close in the last trading session was $10.32, moving within a range at $10.35 and $14.65. The PE ratio in trailing twelve months stood at 72.27. Turning to its 52-week performance, $14.99 and $8.20 were the 52-week high and 52-week low respectively. Overall, DRTS moved 9.38% over the past month.

Alpha Tau Medical Ltd.’s market cap currently stands at around $1.02 billion.

Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s).

1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend DRTS as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.

DRTS’s current price about 9.83% and 15.13% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 56.48, while 7-day volatility ratio is 18.63% and 17.82% in the 30-day chart. Further, Alpha Tau Medical Ltd. (DRTS) has a beta value of 0, and an average true range (ATR) of 1.82. Analysts have given the company’s stock an average 52-week price target of $18.00, forecast between a low of $18.00 and high of $18.00. Looking at the price targets, the low is -52.8% off current price level while to achieve the yearly target high, price needs to move -52.8%. Nonetheless, investors will most likely welcome a -52.8% jump to $18.00 which is the analysts’ median price.

In the market, a comparison of Alpha Tau Medical Ltd. (DRTS) and its peers suggest the former has performed considerably stronger. Data shows DRTS’s intraday price has changed 14.15% in last session and 21.19% over the past year. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are down -1.23% and -1.29% respectively in the last trading.

If we refocus on Alpha Tau Medical Ltd. (NASDAQ:DRTS), historical trading data shows that trading volumes averaged 0.69 million over the past 10 days and 339.30K over the past 3 months. The company’s latest data on shares outstanding shows there are 34.38 million shares.

Current price change has pushed the stock 19.96% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the DRTS stock continues to rise going into the next quarter.